ProPhase Labs introduces Project ZenQ-AI for cancer treatment research, utilizing its advanced AI platform
The platform, along with data from the BE-Smart Test for esophageal adenocarcinoma (EAC), is used to develop algorithms for identifying potential antibody-drug conjugate (ADC) candidates for new cancer therapeutics
The AI platform integrates extensive genomic data from six years of whole genome sequencing tests across 130 countries
Whole Genome Sequencing (WGS) provides comprehensive genetic data, capturing all three billion base pairs for precise genetic analysis
Compared to SNP testing, WGS offers up to 30,000 times more genetic data, enhancing precision in personalized medicine and genetic research